ATRA vs. AUTL

The year-to-date returns for both investments are quite close, with ATRA having a -45.38% return and AUTL slightly higher at -43.83%.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Atara Biotherapeutics, Inc. (ATRA) and Autolus Therapeutics plc (AUTL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current ATRA Sharpe Ratio is -0.40, which is higher than the AUTL Sharpe Ratio of -0.91. The chart below compares the historical Sharpe Ratios of ATRA and AUTL, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Neither ATRA nor AUTL has paid dividends to shareholders.

The maximum ATRA drawdown since its inception was -99.67%, roughly equal to the maximum AUTL drawdown of -97.63%. Use the drawdown chart below to compare losses from any high point for ATRA and AUTL. For additional features, visit the drawdowns tool.

The current volatility for Atara Biotherapeutics, Inc. (ATRA) is 24.94%, while Autolus Therapeutics plc (AUTL) has a volatility of 32.75%. This indicates that ATRA experiences smaller price fluctuations and is considered to be less risky than AUTL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Atara Biotherapeutics, Inc. and Autolus Therapeutics plc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.